+ All Categories
Home > Documents > Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Date post: 25-Dec-2015
Category:
Upload: bathsheba-austin
View: 214 times
Download: 0 times
Share this document with a friend
Popular Tags:
22
ADVANCED THERAPY IN EQUINE LAMENESS Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates www.greenelewis.com
Transcript
Page 1: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

ADVANCED THERAPY IN EQUINE LAMENESS

Hunter S. Lewis, DVM, DABVPGreene, Lewis and Associates

www.greenelewis.com

Page 2: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteocondritis Dessicans (OCD)

1. Degenerative Joint Disease (DJD)2. Characterized by cartilage

damage, new bone formation and joint effusion.

3. Caused by “use trauma”

Osteoarthritis

Subcondral Bone Cysts

Page 3: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteoarthritis Fetlock

Page 4: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteoarthritis

Fetlock

Page 5: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteoarthritis Hock

Page 6: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteocondritis Dessicans (OCD)

1. Developmental Orthopedic Disease (DOD)

2. Characterized by failure of normal bone formation

Osteoarthritis

Subcondral Bone Cysts

Page 7: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

3. Causes:

a. Genetic predispositionb. Rapid growthc. Nutritiond. Mineral Imbalancese. Endocrine Factors

4. Can result in DJD

Osteoarthritis

Osteocondritis Dessicans (OCD)

Subcondral Bone Cysts

Page 8: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteocondritis Dessicans (OCD)

Stifle

Page 9: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Osteocondritis Dessicans (OCD)

Hock

Page 10: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

1. Development Orthopedic Disease2. Characterized by failure of normal bone

formation and loss of normal bone3. Same causes as OCD but trauma is also

involved.4. Can result in DJD

Osteoarthritis

Osteocondritis Dessicans (OCD)

Subcondral Bone Cysts

Page 11: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Subcondral Bone Cysts

Stifle

Page 12: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Subcondral Bone Cysts

Stifle

Page 13: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Subcondral Bone Cysts

Fetlock

Page 14: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Assessment of Joint Treatment

Symptom-Modifying Osteoarthritis Drug (SMOAD)

Disease-Modifying Osteoarthritis Drug (DMOAD)

Page 15: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint Treatment

Oral

Injectable

Intra-articular

Page 16: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint Treatment

Oral

1. Glucosamin2. Chondrotin Sulfate3. Anti-inflammatories4. ASU – Avocado, Soybean

Unsaponifiable Extracts

Page 17: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint TreatmentOral

4. ASU – Avocado, Soybean Unsaponifiable Extracts

a. Did not improve lamenessb. Reduced damage to jointc. Increased production of

glycosaminoglycand. Stimulated cell and tissue repair

Page 18: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint Treatment

Injectable

1. Adequon2. Legend3. Generics

a. Polyglycanb. Map 5

4. Tildren

Page 19: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint TreatmentInjectable

4. Tildren

Inhibits bone resorption and may promote bone reformation

Shown effective in hock osteoarthritis and navicular syndrome

Most effective if used early in disease Cost ??

Page 20: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint TreatmentIntra-articular

1. Corticosteroids2. Hyaluronic Acid3. IRAP – Interleukin-1 Receptor

Antogonist Protein

Page 21: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint TreatmentIntra-articular

3. IRAP – Interleukin-1 Receptor Antogonist Protein

or ACS – Autologous Condition Serum Blocks IL-1 release Reduces negative effects of

inflammation Reduces pain Improves synovial membrane

health

Page 22: Hunter S. Lewis, DVM, DABVP Greene, Lewis and Associates .

Types of Joint TreatmentOther

1. Extrocorporeal Shockwave Therapy

2. Surgery3. Alternative Therapies


Recommended